Fas ligand: A sensor for DNA damage critical in skin cancer etiology

Science

Volumn 285, Issue 5429, 1999, Pages 898-900

  Hill, Laurie L ^a   Ouhtit, Allal ^a   Loughlin, Susan M ^a   Kripke, Margaret L ^a   Ananthaswamy, Honnavara N ^a   Owen Schaub, Laurie B ^a  

^a UNIVERSITY OF TEXAS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FAS ANTIGEN; FAS LIGAND; PROTEIN P53;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIGEN BINDING; APOPTOSIS; ARTICLE; CONTROLLED STUDY; DNA DAMAGE; DNA REPAIR; GENE MUTATION; HISTOPATHOLOGY; MOLECULAR DYNAMICS; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DETERMINATION; PROTEIN INDUCTION; SKIN CARCINOGENESIS; SKIN CARCINOMA; SKIN PROTECTION; STRAIN DIFFERENCE; TUMOR SUPPRESSOR GENE; ULTRAVIOLET B RADIATION;

ANIMALS; ANTIGENS, CD95; APOPTOSIS; DNA DAMAGE; EPIDERMIS; FAS LIGAND PROTEIN; GENES, P53; KERATINOCYTES; MEMBRANE GLYCOPROTEINS; MICE; MICE, INBRED C3H; MUTATION; SKIN NEOPLASMS; ULTRAVIOLET RAYS; UP-REGULATION;

ANIMALIA;

EID: 0033529581     PISSN: 00368075     EISSN: None     Source Type: Journal    
DOI: 10.1126/science.285.5429.898     Document Type: Article

References (28)

1. H. S. Kahn, L. M. Tathum, A. V. Patel, M. J. Thun, C. W. Health, J. Am. Med. Assoc. 280, 910 (1998).
2. A. Ziegler et al., Nature 372, 773 (1994).
3. D. E. Brash, Nature Med. 2, 525 (1996).
4. C. Li, V. Tron, V. Ho, J. Invest. Dermatol. 110, 72 (1998).
5. S. Nagata, Cell 88, 355 (1997).
6. H. Chan, D. P. Bartos, L. B. Owen-Schaub, Mol. Cell. Biol. 19, 2098 (1999).
7. S. Kasibhatla et al., Mol. Cell 1, 543 (1998).
8. C. Gutierrez-Steil et al., J. Clin. Invest. 101, 33 (1998).
9. P. Galle et al., J. Exp. Med. 182, 1223 (1995).
10. M. Muller et al., J. Clin. Invest. 99, 403 (1997).
11. M. Muller et al., J. Exp. Med. 188, 2033 (1998).
12. 2) corresponding to 2.3 minimal erythemal doses for C3H mice.
13. Formaldehyde-fixed skin biopsies were paraffin-embedded, and immunohistochemistry was performed as previously described (27) with polydonal goat antibody to Fas (X-20), FasL (M-20) (Santa Cruz Biotechnology, Santa Cruz, CA), or normal goat serum (isotype control) at final dilutions of 1:500. Staining was visualized with stable diaminobenzidine (Research Genetics, Huntsville, AL). Specificity of staining was confirmed with blocking peptides; preincubation of antibody with specific peptide eliminated all staining. FasL staining was also verified with a monoclonal antibody to FasL (KAY-10; Pharmingen).
14. Shaved dorsal skins were fixed in buffered 10% formalin and embedded in paraffin. Five-micrometer sections were stained with hematoxytin-eosin and examined by light microscopy. Criteria for scoring sunburn cells were intensely staining eosinophilic cytoplasm, pycnotic nuclei, and separation from adjacent cells as previously described (2). For each of two to five mice per point, 10 hematoxytin-eosin sections from two separate epidermal sections were counted for sunburn cells. Sunburn celt incidence was calculated per linear centimeter of epidermis with coded slides that did not reveal treatment group. No detectable differences between wild-type and gld/gld mice in morphology, organization, or thickness were observed in the epidermis.
15. Dorsal skins were fixed in buffered 10% formalin and embedded in paraffin. TUNEL assay was done with a commercially available kit according to the manufacturer's directions (Promega, Madison, WI). Slides were examined with an Olympus Inverted System Microscope 1X70 (Melville, NY), and pictures were taken with a Nikon 35-mm camera (magnification, X 10).
16. L. L. Hill et al., data not shown.
17. Data can be accessed at www.sciencemag.org/ feature/data/1040041.shl
18. L. L. Hill and L. B. Owen-Schaub, unpublished observations.
19. A. S. Jonason et al., Proc. Natl. Acad. Sci. U.S.A. 93, 14025 (1996).
20. S. Kanjilal, W. E. Pierceall, K. K. Cummings, M. L. Kripke, H. N. Ananthaswamy, Cancer Res. 53, 2961 (1993).
21. H. N. Ananthaswamy et al., Photochem. Photobiol. 67, 227 (1998).
22. 2 pieces of dorsal skin from the midline of each mouse was separated from the dermis by floating the skin dermis side down in phosphate-buffered saline containing 0.25% trypsin for 2 hours at 37°C followed by mechanical separation and freezing of epidermis. Frozen epidermis was digested in lysis buffer [4 M urea, 0.5% N-lauroylsarcosine, 10 mM EDTA, 0.2 M NaCl, and 100 mM tris-HCI (pH 8.0)] containing proteinase K (300 μg/ ml) and ribonuclease (100 μg/ml) at 37°C overnight. Samples were heated at 60° for 15 min, and the DNA was extracted with the phenol-chloroform method. The primer sequences used were as follows: codon 270, 5′-GGACGGGACAGCT TTGAGGTTT-3′ (forward); codon 275, 5′-GTGTTTGTGCCTGCCT-3′ (forward); and 3′ prime end of exon 8, 5′-GCCTGCGTACCTCTCTTTGC-3′. The PCR product was resolved on a 6% polyacrylamide gel and visualized on autoradiographic film.
23. H. N. Ananthaswamy et al., Nature Med. 3, 510 (1997).
24. T. S. Griffith, T. Brunner, S. M. Fletcher, D. R. Green, T. A. Ferguson, Science 270, 1189 (1995).
25. L. L. Hill, V. K. Shreedhar, M. L. Kripke, L. B. Owen-Schaub, J. Exp. Med. 189, 1275 (1999).
26. M. S. Fisher and M. L. Kripke, Science 216, 1133 (1982).
27. L. B. Owen-Schaub, K. L. van Golen, L. L. Hill, J. E. Price, J. Exp. Med. 188, 1717 (1998).
28. We thank L. Eichler for expert technical assistance and M. Duvic and D. McConkey for critical review of this manuscript. This work was supported by grants from the Skin Cancer Foundation, American Cancer Society (CIM-96070 to L.O.-S.), and NIH (CA45623 to H.N.A. and CA52457 to L.O-S.). LLH. is the recipient of the Crockrell University Cancer Fighters Scientific Achievement Award and an NIH postdoctoral fellowship (F32 AI09351).